Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Industry News

Terumo Cardiovascular Group and Talis Clinical Introduce ACG-Perfusion™ and ACG-RemoteView™ Systems, Enhancing Efficiency of Clinical Care Team

May 07, 2019

News Industry News

Shifamed Announces $15.5M Series a Financing Supira Medical, Newly Formed Portfolio Company, Focuses on Next Generation PVAD

June 13, 2018

News Industry News

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

October 12, 2015

News Industry News

Terumo Launches The MISAGO® RX Self-Expanding Peripheral Stent To U.S. Market

June 18, 2015

News Industry News

China Interventional Cardiovascular Device Industry Report, 2014-2017

May 27, 2015

News Industry News

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

September 15, 2014

News Industry News

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

September 12, 2014

News Industry News

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

October 31, 2013

News Industry News

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

October 31, 2013

News Industry News

Novel Study Finds Using Radial Versus Femoral Access During Cardiac Catheterization May Have Benefits in Women

October 29, 2013

News Industry News

Thoratec acquires Terumo's DuraHeart II for up to $44M

July 01, 2013

News Industry News

Thoratec Acquires DuraHeart® II Ventricular Assist System

July 01, 2013

News Industry News

Study Confirms that Intracoronary and Intravenous Use of ABCIXIMAB During Angioplasty Yield Similar Results

October 25, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Industry News

Virmani's crystal ball: Transcatheter valves

November 06, 2011

News Industry News

German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device

July 19, 2011

Advertisement

Terumo Cardiovascular Group and Talis Clinical Introduce ACG-Perfusion™ and ACG-RemoteView™ Systems, Enhancing Efficiency of Clinical Care Team

Shifamed Announces $15.5M Series a Financing Supira Medical, Newly Formed Portfolio Company, Focuses on Next Generation PVAD

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

Terumo Launches The MISAGO® RX Self-Expanding Peripheral Stent To U.S. Market

China Interventional Cardiovascular Device Industry Report, 2014-2017

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

Novel Study Finds Using Radial Versus Femoral Access During Cardiac Catheterization May Have Benefits in Women

Thoratec acquires Terumo's DuraHeart II for up to $44M

Thoratec Acquires DuraHeart® II Ventricular Assist System

Study Confirms that Intracoronary and Intravenous Use of ABCIXIMAB During Angioplasty Yield Similar Results

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

Low CV Event Rate Prompts Closure of Prasugrel Trial

Virmani's crystal ball: Transcatheter valves

German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content